{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05024695",
            "orgStudyIdInfo": {
                "id": "ISM06"
            },
            "organization": {
                "fullName": "iSTAR Medical",
                "class": "INDUSTRY"
            },
            "briefTitle": "Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject\u2122 Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.",
            "officialTitle": "A Prospective, Multicenter Masked Clinical Trial to Evaluate the Safety and Effectiveness of the MINIject CS627 Implant in Subjects With Open Angle Glaucoma",
            "acronym": "STAR-V",
            "therapeuticArea": [
                "Ophthalmology"
            ],
            "study": "evaluate-the-safety-and-effectiveness-of-istar-medical-s-miniject-implant-for-lowering-intraocular-pressure-iop-in-subjects-with-primary-open-angle-glaucoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2021-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-08-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-08-23",
            "studyFirstSubmitQcDate": "2021-08-23",
            "studyFirstPostDateStruct": {
                "date": "2021-08-27",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2021-08-23",
            "lastUpdatePostDateStruct": {
                "date": "2021-08-27",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "iSTAR Medical",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "Evaluate the safety and effectiveness of iSTAR Medical's MINIject\u2122 implant for lowering intraocular pressure (IOP) in subjects with primary open-angle glaucoma.",
            "detailedDescription": "This is a prospective, multicenter, masked clinical trial to evaluate the safety and effectiveness of iSTAR Medical's MINIject\u2122 implant for lowering intraocular pressure (IOP) in subjects with primary open-angle glaucoma."
        },
        "conditionsModule": {
            "conditions": [
                "Glaucoma"
            ],
            "keywords": [
                "glaucoma",
                "MIGS",
                "primary open angle glaucoma",
                "suprachoroidal space",
                "supraciliary space"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "The MINIject\u2122 SO627 is an integrated system for Minimally Invasive Glaucoma Surgery (MIGS) comprised of a glaucoma drainage implant, the MINIject\u2122 SO627 and the SO Delivery System, designed to deliver the MINIject\u2122 implant into the supraciliary space. The MINIject\u2122 SO627 implant is manufactured from proprietary STAR\u00ae silicone material.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE",
                    "maskingDescription": "Person(s) checking intraocular pressures are masked, except for day of surgery, throughout the duration of the trial."
                }
            },
            "enrollmentInfo": {
                "count": 975,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Implant Group",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Device: MINIject\u2122 Implant"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "MINIject\u2122 Implant",
                    "description": "The MINIject\u2122 SO627 is an integrated system for Minimally Invasive Glaucoma Surgery (MIGS) comprised of a glaucoma drainage implant, the MINIject\u2122 SO627 and the SO Delivery System, designed to deliver the MINIject\u2122 implant into the supraciliary space.",
                    "armGroupLabels": [
                        "Implant Group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Intraocular pressure decrease",
                    "description": "Proportion of subjects with \u2265 20% decrease (responders) from Baseline in unmedicated DIOP at Month 24.",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Intraocular pressure decrease (outcome 2)",
                    "description": "Change from baseline in mean unmedicated diurnal IOP at Month 24.",
                    "timeFrame": "24 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Males and females, 46 years of age or older\n* A diagnosis of primary open-angle glaucoma, who are candidates for medical therapy, laser treatment, or glaucoma-filtering surgery\n* Pseudophakic with prior uncomplicated cataract surgery\n\nKey Exclusion Criteria:\n\n* Angle closure, congenital, or secondary glaucoma\n* Diagnosed degenerative visual disorders\n* Clinically significant intraocular inflammation or infection",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "46 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Abhi Vilupuru, Ph.D",
                    "role": "CONTACT",
                    "phone": "714-914-5527",
                    "email": "abhi.vilupuru@istarmed.us"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Abhi Vilupuru, Ph.D",
                    "affiliation": "iSTAR Medical",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "Vold Vision",
                    "status": "RECRUITING",
                    "city": "Fayetteville",
                    "state": "Arkansas",
                    "zip": "72704",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Steve Vold",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Steve Vold, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.06258,
                        "lon": -94.15743
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005901",
                    "term": "Glaucoma"
                },
                {
                    "id": "D000005902",
                    "term": "Glaucoma, Open-Angle"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009798",
                    "term": "Ocular Hypertension"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9013",
                    "name": "Glaucoma",
                    "asFound": "Glaucoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9014",
                    "name": "Glaucoma, Open-Angle",
                    "asFound": "Open Angle Glaucoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M12731",
                    "name": "Ocular Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                }
            ]
        }
    },
    "hasResults": false
}